Henry Ji
Modulasetulo, Mopresidente le CEO
- Lilemo tse 25+ tsa boiphihlelo indastering ea biotechnology le mahlale a bophelo
- Dr. Ji o thehile Sorrento mme o sebelitse e le motsamaisi ho tloha 2006, CEO le Mopresidente ho tloha 2012, le Molula-setulo ho tloha 2017.
- Nakong ea nako ea hae Sorrento, o thehile le ho etella pele kholo e makatsang ea Sorrento ka ho fumana le ho kopanya ho kenyelletsa Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Animal Health, le Sofurysa Systems Lymphatic.
- O sebelitse joalo ka Ofisiri e ka Sehloohong ea Saense ea Sorrento ho tloha 2008 ho isa 2012 hape e le CEO oa Nako ea nakoana ho tloha 2011 ho isa 2012.
- Pele ho Sorrento, o ne a tšoere maemo a phahameng ho CombiMatrix, Stratagene hape a theha Stratagene Genomics, e leng setsi sa Stratagene, mme a sebetsa joalo ka Mopresidente le CEO le Motsamaisi oa Boto.
- BS le Ph.D.
Kwala X
Dorman Latela
motsamaisi
- Mong. Followwill, o sebelitse e le motsamaisi ho tloha ka Loetse 2017
- E bile Senior Partner, Transformational Health ho Frost & Sullivan, feme ea boeletsi ea khoebo e amehang lipatlisisong le tlhahlobong ea 'maraka, tlhahlobo ea maano a kholo le koetliso ea likhoebo ho pholletsa le liindasteri tse ngata, ho tloha 2016.
- Pele ho nako eo, o ile a sebeletsa mesebetsing e sa tšoaneng Frost & Sullivan, ho kopanyelletsa le Molekane oa Komiti ea Phethahatso e laolang P & L ea khoebo ea Europe, Iseraele le Afrika, le Molekane ea okametseng khoebo ea Healthcare le Life Sciences Amerika Leboea, ho tloha ha a qala ho kopanela. Frost & Sullivan ho thusa ho fumana mokhoa oa Consulting ka Pherekhong 1988
- Mong. Followwill o na le lilemo tse fetang 30 tsa boetapele ba mokhatlo le boiphihlelo ba boeletsi ba botsamaisi, a sebelitse mererong e makholo ea boeletsi libakeng tsohle tse kholo le makaleng a mangata a indasteri, morero o mong le o mong o tsepamisitse maikutlo holima bohlokoa ba leano la kholo.
- BA
Kwala X
Kim D. Janda
motsamaisi
- Dr. Janda o sebeditse e le motsamaisi ho tloha ka Mmesa 2012
- Dr. Janda e 'nile ea e-ba Ely R. Callaway, Jr. Motlatsi oa Moprofesa Lefapheng la Chemistry, Immunology le Microbial Science ho The Scripps Research Institute ("TSRI") ho tloha 1996 le Mookameli oa Worm Institute of Research and Medicine ( "WIRM") ho TSRI ho tloha 2005. Ho feta moo, Dr. Janda o sebelitse e le Setsebi sa Skaggs ka hare ho Skaggs Institute of Chemical Biology, hape e le TSRI, ho tloha 1996.
- O hatisitse likhatiso tsa mantlha tse fetang 425 likoranteng tse hlahlobiloeng ke lithaka mme a theha lik'hamphani tsa biotechnology CombiChem, Drug Abuse Sciences le AIPartia Dr. Janda ke motlatsi oa mohlophisi oa "Bioorganic & Medicinal Chemistry", "PLoS ONE" mme o sebeletsa, kapa o kile a sebeletsa. , libotong tsa bahlophisi tsa limakasine tse ngata tse akarelletsang J. Comb. Chem., Chem. Maikutlo, J. Med. Chem., The Botulinum Journal, Bioorg. & Med. Chem. Lett., le Bioorg. & Med. Chem
- Nakong ea mosebetsi oa lilemo tse fetang 25, Dr. Janda o fane ka liphallelo tse ngata 'me o nkoa e le e mong oa bo-rasaense ba pele ba ho kopanya mekhoa ea lik'hemik'hale le ea baeloji lenaneong le kopanetsoeng la lipatlisiso.
- Dr. Janda o sebelelitse Botong ea Keletso ea Saense ea Materia le Lekala la Thuto la Singapore
- BS le Ph.D.
Kwala X
David Lemus
motsamaisi
- Mong. Lemus o sebelitse e le motsamaisi oa Khampani ho tloha ka Loetse 2017
- Hajoale ke CEO oa Ironshore Pharmaceuticals, Inc.
- Ho feta moo, o sebetsa joalo ka setho sa boto eo e seng ea phethahatso ea Silence Therapeutics (NASDAQ: SLN) le BioHealth Innovation, Inc.
- Pele a le Sigma Tau Pharmaceuticals, Inc. ho tloha 2011-2015, o sebelitse joalo ka CEO.
- Ho feta moo, Monghali Lemus o sebelitse joalo ka CFO le Motlatsi oa Motlatsi oa Motlatsi oa MorphoSys AG ho tloha ka 1998-2011, 'me o ile a kenya k'hamphani ho IPO ea pele ea biotech ea Jeremane.
- Pele ho karolo ea hae ho MorphoSys AG, o ne a tšoere maemo a fapaneng a botsamaisi ho kenyeletsa le lik'hamphani Hoffman La Roche, Electrolux AB, le Lindt & Spruengli AG (Treasurer ea Sehlopha)
- BS, MS, MBA, CPA
Kwala X
Jaisim Shah
motsamaisi
- Mong. Shah o sebelitse e le motsamaisi ho tloha ka 2013
- Lilemo tse 25+ tsa boiphihlelo indastering ea meriana
- Mong. Shah hajoale o sebetsa e le CEO le Mopresidente oa Scilex Holding le Scilex Pharmaceutical.
- Pele ho Scilex, o sebelitse e le CEO le Mopresidente oa Semnur Pharmaceuticals (e fumanoeng ke Scilex Pharmaceuticals) ho tloha ha e qala ka 2013.
- Ho tloha 2011 ho isa 2012, o sebelitse e le Ofisiri e ka Sehloohong ea Khoebo ea Elevation Pharmaceuticals moo a neng a tsepamisitse maikutlo ho lichelete, ho kopanya le ho reka, le nts'etsopele ea khoebo.
- Pele ho Phahamiso, Monghali Shah e ne e le Mopresidente oa Zelos Therapeutics, moo a neng a tsepamisitse maikutlo ho lichelete le nts'etsopele ea khoebo.
- Pele ho Zelos, Monghali Shah e ne e le Motlatsi e Moholo oa Motlatsi le Mookameli oa Khoebo oa CytRx. Pejana, Monghali Shah e ne e le Ofisiri e ka Sehloohong ea Khoebo ho Facet Biotech le PDL BioPharma moo a ileng a phethela liteishene tse ngata tsa laesense / tšebelisano 'moho le maano.
- Pele ho PDL, Monghali Shah e ne e le Motlatsi oa Motlatsi oa Global Marketing ho BMS moo a ileng a amohela "Moputso oa Mopresidente" bakeng sa ho phethela e 'ngoe ea litšebelisano tsa bohlokoa ka ho fetisisa historing ea k'hamphani.
- MA le MBA
Kwala X
Ke Alexander Wu
motsamaisi
- Dr. Wu o sebelitse e le motsamaisi ho tloha ka Phato 2016
- Hajoale o boetse o sebetsa ho BOD ea Scilex Pharmaceutical ho tloha 2019
- Dr. Wu e ne e le mothehi-'moho, CEO, Mopresidente, le Ofisiri e ka Sehloohong ea Saense ea Crown Bioscience International, k'hamphani e etellang pele ea lefats'e ea ho sibolla lithethefatsi le tharollo ea ntlafatso, eo a e thehileng hammoho ka 2006.
- Ho tloha 2004 ho isa 2006, e ne e le Mookameli oa Khoebo oa Starvax International Inc. Beijing, Chaena, k'hamphani ea biotechnology e shebaneng le oncology le mafu a tšoaetsanoang.
- Ho tloha 2001 ho isa 2004, e ne e le rabanka le Burrill & Company moo e neng e le hlooho ea Asia Activities.
- BS, MS, MBA, le Ph.D.
Kwala X